Given the clinical significance of BCR-ABL in leukemia treatment, we sought to investigate the roles of BCR-ABL in CML and its relationship with telomerase regulation, in order to facilitate in the development of better anti-CML drugs. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.